---
url: "https://www.lek.com/leadership/simon-middleton"
title: "Simon Middleton | L.E.K. Consulting"
---

[Skip to main content](https://www.lek.com/leadership/simon-middleton#main-content)

[![L.E.K.](https://www.lek.com/themes/lek/images/new-logo.svg)](https://www.lek.com/ "L.E.K.")

Search

- English
- List additional actions
- [Português](https://www.lek.com/pt-br/lek-brazil)
- [简体中文](https://www.lek.com/zh-hant/lek-china)
- [Deutsch](https://www.lek.com/de/lek-germany)
- [日本語](https://www.lek.com/ja/lek-japan)

# Simon Middleton

Simon Middleton is a Partner at L.E.K. Consulting. He is a member of the Life Sciences practice and has worked for both clients and investors in the pharmaceutical, biotech and medtech industries. Simon has extensive experience across a range of therapeutic areas including cardiovascular diseases, metabolic diseases, pain and oncology. Simon holds a Masters in Biological Sciences from Oxford University, and an MPhil and Ph.D. in biological anthropology from the University of Cambridge, where he specialized in molecular genetics.

### Education

**Undergraduate:** MA in Biological Sciences from the University of Oxford

**Graduate:** MPhil, Biological Anthropology, and PhD, Biological Anthropology from the University of Cambridge

![Simon Middleton](https://www.lek.com/sites/default/files/profile-images/LEK_Leader_Profile_Simon_Middleton.jpg)

### Simon's Expertise

#### Industries

[Life Sciences Consulting](https://www.lek.com/industries/life-sciences-pharma)

[Biotech and Pharmaceuticals](https://www.lek.com/industries/life-sciences-pharma/biotech-pharmaceutical)

[MedTech](https://www.lek.com/industries/medtech)

[Medical Equipment](https://www.lek.com/industries/medtech/medical-equipment)

[Drug Delivery](https://www.lek.com/industries/life-sciences-pharma/drug-delivery)

[Private Equity Consulting](https://www.lek.com/industries/private-equity-pe)

[Commercial Due Diligence](https://www.lek.com/industries/private-equity-pe/commercial-due-diligence-cdd)

[Vendor Due Diligence](https://www.lek.com/industries/private-equity-pe/vendor-due-diligence-vdd)

#### Capabilities

[Mergers & Acquisitions](https://www.lek.com/capabilities/mergers-acquisitions)

[Strategy](https://www.lek.com/capabilities/strategy)

Read more

### Related Insights

[Executive Insights\\
\\
\\
**Life Sciences & Pharma****From Bench to Bedside: Academic-to-Industry Translation in European Biopharma**\\
\\
June 25, 2025](https://www.lek.com/insights/hea/eu/ei/bench-bedside-academic-industry-translation-european-biopharma)

[Executive Insights\\
\\
\\
**Life Sciences & Pharma****Animal Pharma: Unlocking Value Through Growth and Investment**\\
\\
May 21, 2025](https://www.lek.com/insights/hea/eu/ei/animal-pharma-unlocking-value-through-growth-and-investment)

[Smart Chart\\
\\
\\
**Life Sciences & Pharma****The Future of Animal Health: At a Glance**\\
\\
April 14, 2025](https://www.lek.com/insights/hea/eu/sc/future-animal-health-glance)

[Executive Insights\\
\\
\\
**Life Sciences & Pharma****The Future of Animal Health: Strategic Lessons from Human Healthcare**\\
\\
March 17, 2025](https://www.lek.com/insights/hea/eu/ei/future-animal-health-strategic-lessons-human-healthcare)

[Article\\
\\
\\
**Life Sciences & Pharma****Impact of the US BIOSECURE Act on Biopharmas, Contract Services and Investors**\\
\\
July 2, 2024](https://www.lek.com/insights/hea/global/ar/impact-us-biosecure-act-biopharmas-contract-services-and-investors)

[Special Report\\
\\
\\
**Life Sciences & Pharma****The Financial Ecosystem of Pharmaceutical R&D**\\
\\
July 14, 2022](https://www.lek.com/insights/sr/financial-ecosystem-pharmaceutical-rd)

- [Load more](https://www.lek.com/leadership/simon-middleton?page=1 "Load more items")

First name

Last name

Email

Phone number

My locationUnited StatesCanadaAfghanistanAlbaniaAlgeriaAmerican SamoaAndorraAngolaAnguillaAntarcticaAntigua and BarbudaArgentinaArmeniaArubaAustraliaAustriaAzerbaijanBahamasBahrainBangladeshBarbadosBelarusBelgiumBelizeBeninBermudaBhutanBoliviaBosnia and HerzegovinaBotswanaBrazilBritish Indian Ocean TerritoryBritish Virgin IslandsBruneiBulgariaBurkina FasoBurundiCambodiaCameroonCape VerdeCayman IslandsCentral African RepublicChadChileChinaChristmas IslandCocos (Keeling) IslandsColombiaComorosCongoCook IslandsCosta RicaCroatiaCubaCuraçaoCyprusCzech RepublicCôte d’IvoireDemocratic Republic of the CongoDenmarkDjiboutiDominicaDominican RepublicEcuadorEgyptEl SalvadorEquatorial GuineaEritreaEstoniaEthiopiaFalkland IslandsFaroe IslandsFijiFinlandFranceFrench GuianaFrench PolynesiaFrench Southern TerritoriesGabonGambiaGeorgiaGermanyGhanaGibraltarGreeceGreenlandGrenadaGuadeloupeGuamGuatemalaGuernseyGuineaGuinea-BissauGuyanaHaitiHondurasHong Kong S.A.R., ChinaHungaryIcelandIndiaIndonesiaIranIraqIrelandIsle of ManIsraelItalyJamaicaJapanJerseyJordanKazakhstanKenyaKiribatiKuwaitKyrgyzstanLaosLatviaLebanonLesothoLiberiaLibyaLiechtensteinLithuaniaLuxembourgMacao S.A.R., ChinaMacedoniaMadagascarMalawiMalaysiaMaldivesMaliMaltaMarshall IslandsMartiniqueMauritaniaMauritiusMayotteMexicoMicronesiaMoldovaMonacoMongoliaMontenegroMontserratMoroccoMozambiqueMyanmarNamibiaNauruNepalNetherlandsNew CaledoniaNew ZealandNicaraguaNigerNigeriaNiueNorfolk IslandNorth KoreaNorthern Mariana IslandsNorwayOmanPakistanPalauPalestinian TerritoryPanamaPapua New GuineaParaguayPeruPhilippinesPitcairnPolandPortugalPuerto RicoQatarRomaniaRussiaRwandaRéunionSaint BarthélemySaint HelenaSaint Kitts and NevisSaint LuciaSaint Pierre and MiquelonSaint Vincent and the GrenadinesSamoaSan MarinoSao Tome and PrincipeSaudi ArabiaSenegalSerbiaSeychellesSierra LeoneSingaporeSlovakiaSloveniaSolomon IslandsSomaliaSouth AfricaSouth KoreaSouth SudanSpainSri LankaSudanSurinameSvalbard and Jan MayenSwazilandSwedenSwitzerlandSyriaTaiwanTajikistanTanzaniaThailandTimor-LesteTogoTokelauTongaTrinidad and TobagoTunisiaTurkeyTurkmenistanTurks and Caicos IslandsTuvaluU.S. Virgin IslandsUgandaUkraineUnited Arab EmiratesUnited KingdomUnited States Minor Outlying IslandsUruguayUzbekistanVanuatuVaticanVenezuelaViet NamWallis and FutunaWestern SaharaYemenZambiaZimbabwe

Reason for contactingBusiness - I'm exploring hiring L.E.K.Press - I'm a media representative seeking an L.E.K. expert perspectiveCareer - I'm exploring working at L.E.K.Events - I'm looking to invite L.E.K. to participate in an upcoming eventOther

Company

Message

Comments

By clicking “Contact me” I acknowledge and agree to the L.E.K. Consulting [Privacy Notice](https://www.lek.com/lek-consulting-privacy-policy).

×